Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tel Aviv
SEC filing record 1 source field available
Fiscal year end
31 December
Chemomab Therapeutics Ltd. has filed 352 SEC EDGAR filings since 07 Nov 2011

SEC filing history

Showing 1-25 of 62 matching filings.

Per page
25
Current page
1
6-K File 001-38807

6-K

Filing date
08 Jul 2026
Reporting date
08 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
02 Jun 2026
Reporting date
02 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
14 May 2026
Reporting date
14 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
06 May 2026
Reporting date
06 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
28 Apr 2026
Reporting date
28 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
20 Mar 2026
Reporting date
20 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
19 Mar 2026
Reporting date
19 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
21 Nov 2025
Reporting date
21 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
22 Aug 2025
Reporting date
22 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
25 Jul 2025
Reporting date
25 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
01 Jul 2025
Reporting date
01 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
27 May 2025
Reporting date
27 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
15 May 2025
Reporting date
15 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
15 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
27 Mar 2025
Reporting date
27 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
20 Mar 2025
Reporting date
20 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
03 Mar 2025
Reporting date
03 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
19 Feb 2025
Reporting date
19 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
18 Nov 2024
Reporting date
18 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
14 Nov 2024
Reporting date
14 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
11 Oct 2024
Reporting date
11 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
25 Jul 2024
Reporting date
25 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
12 Jun 2024
Reporting date
12 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .